Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pharmaceutical Vaneck ETF (PPH)

Pharmaceutical Vaneck ETF (PPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 239,729,900
  • Market Capitalization, $K 239,730
  • Shares Outstanding, K 3,788
  • 60-Month Beta 0.90
  • Price/Earnings ttm 25.50
  • Annual Dividend & Yield 1.06 (1.67%)
  • Most Recent Dividend 0.252 on 07/01/20
  • Management Fee 0.36%
  • Sectors:

    ETFs - Healthcare

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.30 +1.34%
on 09/21/20
64.68 -3.96%
on 08/31/20
-1.75 (-2.74%)
since 08/21/20
3-Month
60.90 +2.01%
on 07/09/20
65.43 -5.06%
on 08/06/20
-0.87 (-1.38%)
since 06/19/20
52-Week
46.90 +32.45%
on 03/23/20
68.02 -8.67%
on 02/12/20
+3.88 (+6.66%)
since 09/20/19

Most Recent Stories

More News
Pharma ETFs to Benefit from Lilly's Coronavirus Antibody Progress

Lilly's progress in antibodies treatment is expected to raise investors optimism.

PPH : 62.12 (-1.80%)
PJP : 63.45 (-2.49%)
IHE : 162.66 (-2.87%)
XPH : 44.04 (-2.76%)
ETFs to Gain as AstraZeneca Resumes Coronavirus Vaccine Trial

AstraZeneca's resumption of the late-stage trials can revive investors optimism surrounding the coronavirus vaccine development.

IBB : 132.83 (-2.56%)
CNCR : 27.68 (-4.78%)
XBI : 112.03 (-3.55%)
PPH : 62.12 (-1.80%)
BBH : 156.12 (-0.88%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 62.12 (-1.80%)
AZN : 55.91 (-0.96%)
PFE : 36.02 (-1.67%)
LLY : 151.18 (-1.94%)
PJP : 63.45 (-2.49%)
IHE : 162.66 (-2.87%)
Pharma ETFs Soar on Robust Q2 Earnings

Total earnings of 66.4% of the healthcare market capitalization that has reported so far are up 4.4% on revenue growth of 4%.

JNJ : 145.10 (-2.73%)
PFE : 36.02 (-1.67%)
MRK : 83.13 (-3.12%)
LLY : 151.18 (-1.94%)
BMY : 57.77 (-2.53%)
PPH : 62.12 (-1.80%)
PJP : 63.45 (-2.49%)
IHE : 162.66 (-2.87%)
XPH : 44.04 (-2.76%)
FTXH : 23.87 (-2.43%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 62.12 (-1.80%)
LLY : 151.18 (-1.94%)
BMY : 57.77 (-2.53%)
ABBV : 89.09 (-1.13%)
PJP : 63.45 (-2.49%)
IHE : 162.66 (-2.87%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 62.12 (-1.80%)
TEVA : 8.95 (-5.59%)
AZN : 55.91 (-0.96%)
ABBV : 89.09 (-1.13%)
PJP : 63.45 (-2.49%)
IHE : 162.66 (-2.87%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 62.12 (-1.80%)
AZN : 55.91 (-0.96%)
PFE : 36.02 (-1.67%)
ABBV : 89.09 (-1.13%)
PJP : 63.45 (-2.49%)
IHE : 162.66 (-2.87%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 62.12 (-1.80%)
JNJ : 145.10 (-2.73%)
PFE : 36.02 (-1.67%)
LLY : 151.18 (-1.94%)
PJP : 63.45 (-2.49%)
IHE : 162.66 (-2.87%)
Top-Ranked ETFs & Stocks to Buy From Bargain Industries

Given recovering fundamentals, investors should take advantage of the beaten-down prices. For them, we have highlighted four solid ETF & stock picks each from the industries that are currently undervalued...

AGN : 193.02 (+0.02%)
XLF : 23.93 (-2.49%)
TPH : 17.07 (-1.27%)
ARR : 9.50 (-3.75%)
ITB : 54.20 (-1.81%)
PPH : 62.12 (-1.80%)
MORT : 13.91 (-3.13%)
COOP : 21.15 (-2.62%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 62.12 (-1.80%)
JNJ : 145.10 (-2.73%)
NVO : 68.99 (-0.65%)
PFE : 36.02 (-1.67%)
PJP : 63.45 (-2.49%)
IHE : 162.66 (-2.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade PPH with:

Fund Summary

The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical...

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 63.03
1st Resistance Point 62.57
Last Price 62.12
1st Support Level 61.48
2nd Support Level 60.85

See More

52-Week High 68.02
Last Price 62.12
Fibonacci 61.8% 59.95
Fibonacci 50% 57.46
Fibonacci 38.2% 54.97
52-Week Low 46.90

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar